Works matching DE "RALTEGRAVIR"

Results: 571
    1
    2
    3
    4
    5
    6
    7
    8

    Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries

    Published in:
    Viruses (1999-4915), 2024, v. 16, n. 12, p. 1853, doi. 10.3390/v16121853
    By:
    • Gouissi Anguechia, Davy-Hyacinthe;
    • Bouba, Yagai;
    • Semengue, Ezechiel Ngoufack Jagni;
    • Ka'e, Aude Christelle;
    • Takou, Désiré;
    • Ambe Chenwi, Collins;
    • Beloumou, Grace;
    • Nka, Alex Durand;
    • Basseck Wome, Ulrich Roland;
    • Santoro, Maria Mercedes;
    • Ceccherini-Silberstein, Francesca;
    • Chatté, Adawaye;
    • Montesano, Carla;
    • Cappelli, Giulia;
    • Colizzi, Vittorio;
    • Ndjolo, Alexis;
    • Mbanya, Dora;
    • Ndembi, Nicaise;
    • Perno, Carlo-Federico;
    • Fokam, Joseph
    Publication type:
    Article
    9

    Frequency of Major Transmitted Integrase Resistance in Poland Remains Low Despite Change in Subtype Variability.

    Published in:
    Viruses (1999-4915), 2024, v. 16, n. 10, p. 1597, doi. 10.3390/v16101597
    By:
    • Mielczak, Kaja;
    • Serwin, Karol;
    • Urbańska, Anna;
    • Aksak-Wąs, Bogusz;
    • Karasińska-Cieślak, Malwina;
    • Mularska, Elżbieta;
    • Witor, Adam;
    • Jakubowski, Paweł;
    • Hlebowicz, Maria;
    • Bociąga-Jasik, Monika;
    • Jabłonowska, Elżbieta;
    • Szymczak, Aleksandra;
    • Szetela, Bartosz;
    • Łojewski, Władysław;
    • Parczewski, Miłosz
    Publication type:
    Article
    10
    11
    12

    Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.

    Published in:
    Viruses (1999-4915), 2024, v. 16, n. 4, p. 582, doi. 10.3390/v16040582
    By:
    • Vos, Wilhelm A. J. W.;
    • Vadaq, Nadira;
    • Matzaraki, Vasiliki;
    • Otten, Twan;
    • Groenendijk, Albert L.;
    • Blaauw, Marc J. T.;
    • van Eekeren, Louise E.;
    • Brinkman, Kees;
    • de Mast, Quirijn;
    • Riksen, Niels P.;
    • Stalenhoef, Anton F. H.;
    • van Lunzen, Jan;
    • van der Ven, Andre J. A. M.;
    • Blok, Willem L.;
    • Stalenhoef, Janneke E.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 8, p. 1727, doi. 10.3390/v15081727
    By:
    • Basso, Monica;
    • Battagin, Giuliana;
    • Nicolè, Stefano;
    • Rossi, Maria Cristina;
    • Colombo, Francesco;
    • Pirola, Nicole;
    • Baratti, Stefano;
    • Storato, Silvia;
    • Giovagnorio, Federico;
    • Malagnino, Vincenzo;
    • Alessio, Grazia;
    • Vinci, Antonio;
    • Maurici, Massimo;
    • Sarmati, Loredana;
    • Parisi, Saverio Giuseppe
    Publication type:
    Article
    19

    Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 8, p. 1683, doi. 10.3390/v15081683
    By:
    • Fokam, Joseph;
    • Chenwi, Collins Ambe;
    • Takou, Desire;
    • Santoro, Maria Mercedes;
    • Tala, Valere;
    • Teto, George;
    • Beloumou, Grace;
    • Semengue, Ezechiel Ngoufack Jagni;
    • Dambaya, Beatrice;
    • Djupsa, Sandrine;
    • Kembou, Etienne;
    • Bouba, Nounouce Pamen;
    • Ajeh, Rogers;
    • Cappelli, Giulia;
    • Mbanya, Dora;
    • Colizzi, Vittorio;
    • Ceccherini-Silberstein, Francesca;
    • Perno, Carlo-Federico;
    • Ndjolo, Alexis
    Publication type:
    Article
    20

    Endothelial Glycocalyx Integrity in Treatment-Naïve People Living with HIV before and One Year after Antiretroviral Treatment Initiation.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 7, p. 1505, doi. 10.3390/v15071505
    By:
    • Fragkou, Paraskevi C.;
    • Ikonomidis, Ignatios;
    • Benas, Dimitrios;
    • Kavatha, Dimitra;
    • Moschopoulos, Charalampos D.;
    • Protopapas, Konstantinos;
    • Kostelli, Gavriella;
    • Thymis, John;
    • Mpirmpa, Dionysia;
    • Galani, Irene;
    • Tsakona, Maria;
    • Oikonomopoulou, Chrysanthi;
    • Theocharous, George;
    • Gorgoulis, Vassilis G.;
    • Gallos, Parisis;
    • Tsiodras, Sotirios;
    • Antoniadou, Anastasia;
    • Papadopoulos, Antonios;
    • Triantafyllidi, Helen
    Publication type:
    Article
    21
    22
    23
    24
    25

    Trajectories of CD4 + /CD8 + T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 11, p. 2315, doi. 10.3390/v14112315
    By:
    • Taramasso, Lucia;
    • Falletta, Antonio;
    • Ricci, Elena;
    • Orofino, Giancarlo;
    • Squillace, Nicola;
    • Menzaghi, Barbara;
    • De Socio, Giuseppe Vittorio;
    • Molteni, Chiara;
    • Pellicanò, Giovanni Francesco;
    • Gulminetti, Roberto;
    • Madeddu, Giordano;
    • Sarchi, Eleonora;
    • Vichi, Francesca;
    • Celesia, Benedetto Maurizio;
    • Bonfanti, Paolo;
    • Di Biagio, Antonio
    Publication type:
    Article
    26
    27
    28

    Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 8, p. 1677, doi. 10.3390/v14081677
    By:
    • Pantazis, Nikos;
    • Papastamopoulos, Vasilios;
    • Antoniadou, Anastasia;
    • Adamis, Georgios;
    • Paparizos, Vasilios;
    • Metallidis, Simeon;
    • Sambatakou, Helen;
    • Psichogiou, Mina;
    • Chini, Maria;
    • Chrysos, Georgios;
    • Panagopoulos, Periklis;
    • Sipsas, Nikolaos V.;
    • Barbunakis, Emmanouil;
    • Gogos, Charalambos;
    • Touloumi, Giota
    Publication type:
    Article
    29
    30
    31

    Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 1, p. 163, doi. 10.3390/v14010163
    By:
    • Ciccullo, Arturo;
    • Baldin, Gianmaria;
    • Borghi, Vanni;
    • Lagi, Filippo;
    • Latini, Alessandra;
    • d'Ettorre, Gabriella;
    • Oreni, Letizia;
    • Fusco, Paolo;
    • Capetti, Amedeo;
    • Fabbiani, Massimiliano;
    • Giacomelli, Andrea;
    • Grimaldi, Alessandro;
    • Madeddu, Giordano;
    • Sterrantino, Gaetana;
    • Mussini, Cristina;
    • Di Giambenedetto, Simona
    Publication type:
    Article
    32
    33
    34

    HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †.

    Published in:
    Viruses (1999-4915), 2021, v. 13, n. 4, p. 594, doi. 10.3390/v13040594
    By:
    • Seatla, Kaelo K.;
    • Maruapula, Dorcas;
    • Choga, Wonderful T.;
    • Ntsipe, Tshenolo;
    • Mathiba, Nametso;
    • Mogwele, Mompati;
    • Kapanda, Max;
    • Nkomo, Bornapate;
    • Ramaabya, Dinah;
    • Makhema, Joseph;
    • Mmalane, Mompati;
    • Mine, Madisa;
    • Kasvosve, Ishmael;
    • Lockman, Shahin;
    • Moyo, Sikhulile;
    • Gaseitsiwe, Simani;
    • Grevenynghe, Julien Van
    Publication type:
    Article
    35
    36
    37
    38
    39

    48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277606
    By:
    • Cabello-Ubeda, Alfonso;
    • de Quirós, Juan Carlos López Bernardo;
    • Martín Carbonero, Luz;
    • Sanz, Jesús;
    • Vergas, Jorge;
    • Mena, Álvaro;
    • Torralba, Miguel;
    • Hernández Segurado, Marta;
    • Pinto, Adriana;
    • Tejerina, Francisco;
    • Palmier, Esmeralda;
    • Gutiérrez, Ángela;
    • Vázquez, Pilar;
    • Pulido, Federico;
    • Górgolas, Miguel
    Publication type:
    Article
    40
    41

    Patterns and prognosis of holding regimens for people living with HIV in Asian countries.

    Published in:
    PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264157
    By:
    • Kim, Jung Ho;
    • Jiamsakul, Awachana;
    • Kiertiburanakul, Sasisopin;
    • Huy, Bui Vu;
    • Khusuwan, Suwimon;
    • Kumarasamy, Nagalingeswaran;
    • Ng, Oon Tek;
    • Ly, Penh Sun;
    • Lee, Man-Po;
    • Chan, Yu-Jiun;
    • Gani, Yasmin Mohamed;
    • Azwa, Iskandar;
    • Avihingsanon, Anchalee;
    • Merati, Tuti Parwati;
    • Pujari, Sanjay;
    • Chaiwarith, Romanee;
    • Zhang, Fujie;
    • Tanuma, Junko;
    • Do, Cuong Duy;
    • Ditangco, Rossana
    Publication type:
    Article
    42
    43

    Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.

    Published in:
    2019
    By:
    • de Jong, Wesley;
    • Aerts, Joeri;
    • Allard, Sabine;
    • Brander, Christian;
    • Buyze, Jozefien;
    • Florence, Eric;
    • van Gorp, Eric;
    • Vanham, Guido;
    • Leal, Lorna;
    • Mothe, Beatriz;
    • Thielemans, Kris;
    • Plana, Montse;
    • Garcia, Félipe;
    • Gruters, Rob;
    • iHIVARNA consortium
    Publication type:
    journal article
    44
    45
    46
    47
    48
    49
    50